• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2202-30
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); No Code Available (3191)
Event Date 11/16/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).Additional suspect medical device components involved in the event: product family: dbs-linear leads, upn: (b)(4), model: db-2202-30, serial: (b)(4), batch: 5116865.
 
Event Description
It was reported that the patient experienced chest pain post dbs trial implant procedure.A chest ct revealed a pulmonary embolism.The patient was treated in the icu and was transferred to the normal ward in stable condition.After initial iv administration of heparin, anticoagulation was continued with subcutaneous injection heparin.An endoscopic biopsy of a tumor suspicious lesion in the chest was performed.Histologically no tumor was detected in the specimen.A transthoracic echocardiographic follow up examination continued to show no increased right heart load.The anticoagulation was continued with oral rivaroxaban.The patient was discharged from the hospital on (b)(6) 2020 and will continue anticoagulation treatment for 3 months.The patient will be reevaluated via electrocardiography, and duplex ultrasound, post 3 month anticoagulation treatment.Pulmonary embolism was possibly related to the procedure and not related to the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
RQ   00646-2602
Manufacturer Contact
talar tahmasian
25155 rye canyon loop
valencia, CA 91355
6619494863
MDR Report Key11175547
MDR Text Key226993395
Report Number3006630150-2020-06672
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729905271
UDI-Public08714729905271
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Reporter Occupation Physician
Type of Report Initial
Report Date 01/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date01/11/2021
Device Model NumberDB-2202-30
Device Catalogue NumberDB-2202-30
Device Lot Number5117528
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/18/2020
Initial Date FDA Received01/14/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/12/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-